Logo image of BNRE.CA

BROOKFIELD REINSURANCE LTD (BNRE.CA) Stock Fundamental Analysis

TSX:BNRE - Toronto Stock Exchange - BMG162501057 - Common Stock - Currency: CAD

81.44  +0.93 (+1.16%)

Fundamental Rating

3

Taking everything into account, BNRE scores 3 out of 10 in our fundamental rating. BNRE was compared to 79 industry peers in the Insurance industry. BNRE has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, BNRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year BNRE was profitable.
BNRE had a positive operating cash flow in the past year.
BNRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BNRE had a positive operating cash flow.
BNRE.CA Yearly Net Income VS EBIT VS OCF VS FCFBNRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

1.2 Ratios

BNRE has a Return On Assets of 0.78%. This is comparable to the rest of the industry: BNRE outperforms 57.65% of its industry peers.
The Return On Equity of BNRE (9.30%) is worse than 96.47% of its industry peers.
BNRE has a Return On Invested Capital (0.74%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROIC 0.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNRE.CA Yearly ROA, ROE, ROICBNRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

BNRE has a Profit Margin of 11.15%. This is in the better half of the industry: BNRE outperforms 78.82% of its industry peers.
In the last couple of years the Profit Margin of BNRE has grown nicely.
BNRE has a worse Operating Margin (14.67%) than 65.88% of its industry peers.
BNRE's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.67%
PM (TTM) 11.15%
GM N/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BNRE.CA Yearly Profit, Operating, Gross MarginsBNRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BNRE is destroying value.
BNRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BNRE.CA Yearly Shares OutstandingBNRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
BNRE.CA Yearly Total Debt VS Total AssetsBNRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10B 20B 30B 40B

2.2 Solvency

The Debt to FCF ratio of BNRE is 2.54, which is a good value as it means it would take BNRE, 2.54 years of fcf income to pay off all of its debts.
BNRE's Debt to FCF ratio of 2.54 is in line compared to the rest of the industry. BNRE outperforms 51.76% of its industry peers.
BNRE has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
BNRE has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: BNRE underperforms 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Altman-Z N/A
ROIC/WACC0.1
WACC7.07%
BNRE.CA Yearly LT Debt VS Equity VS FCFBNRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BNRE.CA Yearly Current Assets VS Current LiabilitesBNRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BNRE have decreased strongly by -20.20% in the last year.
BNRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 313.29% yearly.
BNRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.09%.
The Revenue has been growing by 111.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNRE.CA Yearly Revenue VS EstimatesBNRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 193.90 indicates a quite expensive valuation of BNRE.
Based on the Price/Earnings ratio, BNRE is valued expensively inside the industry as 96.47% of the companies are valued cheaper.
BNRE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.35.
Industry RankSector Rank
PE 193.9
Fwd PE N/A
BNRE.CA Price Earnings VS Forward Price EarningsBNRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BNRE indicates a somewhat cheap valuation: BNRE is cheaper than 65.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.25
EV/EBITDA -4.58
BNRE.CA Per share dataBNRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BNRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKFIELD REINSURANCE LTD

TSX:BNRE (11/22/2024, 7:00:00 PM)

81.44

+0.93 (+1.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-08 2024-08-08/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.54B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.76
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 193.9
Fwd PE N/A
P/S 0.28
P/FCF 1.25
P/OCF 1.16
P/B 0.23
P/tB 0.3
EV/EBITDA -4.58
EPS(TTM)0.42
EY0.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)65.08
FCFY79.91%
OCF(TTM)70.43
OCFY86.48%
SpS293.62
BVpS352.09
TBVpS270.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROCE 1.03%
ROIC 0.74%
ROICexc 0.83%
ROICexgc 1%
OM 14.67%
PM (TTM) 11.15%
GM N/A
FCFM 22.16%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Debt/EBITDA 3.5
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.61
Cash Conversion 149.38%
Profit Quality 198.82%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.07%
ROIC/WACC0.1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.76%
EBIT growth 3Y763.81%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.58%
FCF growth 3Y47.68%
FCF growth 5Y55.77%
OCF growth 1Y19.21%
OCF growth 3Y52.3%
OCF growth 5Y58.72%